Sichuan Kelun Pharmaceutical (002422.SZ): Xituximab N01 injection approved for market launch.
Kolun Pharmaceutical (002422.SZ) announced that its subsidiary Sichuan Kolun Botai Biopharmaceutical Co., Ltd.
Sichuan Kelun Pharmaceutical (002422.SZ) announced that its subsidiary Sichuan Kelun Botai Biopharmaceutical Co., Ltd.'s recombinant epidermal growth factor receptor (EGFR) human-mouse chimeric monoclonal antibody - cetuximab injection (formerly known as A140) (Detelai) has been approved by China's National Medical Products Administration (NMPA) for listing in China. It is indicated for use in combination with FOLFOX or FOLFIRI regimens for first-line treatment of RAS wild-type metastatic colorectal cancer, at a dose of 500mg/m2 once every two weeks, or an initial dose of 400mg/m2 followed by a maintenance dose of 250mg/m2 once a week.
Related Articles
HK Stock Market Move | ALI HEALTH (00241) opened down nearly 5%, Alibaba issued HK$12 billion zero-coupon convertible bonds which can be converted into ALI HEALTH shares.
New stock on the first day | Anjoy Foods Group (02648) made its debut on the market. The stock opened flat in the morning, the company is the leading enterprise in China's frozen food industry.
Implementing JD.com's "1000 Chinese Brands Going Global" strategy, JD Industrial has reached a strategic partnership with Hangcha Group.
HK Stock Market Move | ALI HEALTH (00241) opened down nearly 5%, Alibaba issued HK$12 billion zero-coupon convertible bonds which can be converted into ALI HEALTH shares.
New stock on the first day | Anjoy Foods Group (02648) made its debut on the market. The stock opened flat in the morning, the company is the leading enterprise in China's frozen food industry.
Implementing JD.com's "1000 Chinese Brands Going Global" strategy, JD Industrial has reached a strategic partnership with Hangcha Group.
